1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : PHARMACEUTICALS
  4. SHILPA MEDICARE LTD.
Shilpa Medicare Ltd. NSE: SHILPAMED | BSE: 530549
Mid-range Performer
824.85 6.40 (0.78%)
48.62% Gain from 52W Low
364.9K
NSE+BSE Volume
High volume today

NSE 23 Sep, 2025 3:31 PM (IST)

Watchlist

Portfolio

Alert
Drug Approval
Shilpa Medicare gets EMA nod for Rivaroxaban, targeting the European market valued at $2.5 billion See details

Detailed Stock Analysis for Shilpa Medicare Ltd. with Real-time Stock Report

crown icon
Premium Feature
Please subscribe to GuruQ or StratQ
Subscribe Sign in